Pancreatic Cancers with High Grade Tumor Budding Exhibit Hallmarks of Diminished Anti-Tumor Immunity

SIMPLE SUMMARY: Pancreatic cancer, in its most common manifestation pancreatic ductal adenocarcinoma (PDAC), is a uniquely lethal disease with very limited treatment options and few prognostic biomarkers. Tumor budding is a proven independent, adverse prognostic factor in many tumor types including...

Descripción completa

Detalles Bibliográficos
Autores principales: Sadozai, Hassan, Acharjee, Animesh, Gruber, Thomas, Gloor, Beat, Karamitopoulou, Eva
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7961597/
https://www.ncbi.nlm.nih.gov/pubmed/33806316
http://dx.doi.org/10.3390/cancers13051090

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7961597/
https://www.ncbi.nlm.nih.gov/pubmed/33806316
http://dx.doi.org/10.3390/cancers13051090

Ejemplares similares